Independent Ranking Shows More Transparency, More Programs for Low-income Countries. European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.Compared to 2008, when the first Index was published, pharma [...]
|
 |